Zexone TZ 250mg/31.25mg Injection
Marketer
Solace Biotech Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Zexone TZ 250mg/31.25mg Injection
Combiflox TZ, a 250mg/31.25mg injectable formulation, combats diverse bacterial infections. Its action inhibits microbial proliferation, thereby containing infection spread. Administration requires strict medical oversight; missed doses should be avoided, and the prescribed course must be completed regardless of symptom improvement. Premature cessation may compromise efficacy. Common adverse effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate consultation. Allergic reactions (rash, pruritus, edema, dyspnea) demand urgent medical attention. Prior to use, disclose all current medications to your physician. Pregnant or lactating individuals should seek medical advice. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness warrants abstention from driving. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Monitoring via laboratory and diagnostic tests may be employed to assess treatment effectiveness.
Uses of Zexone TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Zexone TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Zexone TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Zexone TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Zexone TZ 250mg/31.25mg Injection works:
The injectable formulation Zexone TZ (250mg/31.25mg) unites ceftriaxone, a bacterial growth inhibitor, with tazobactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a process vital for bacterial viability. Tazobactam augments ceftriaxone's efficacy by counteracting bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Zexone TZ 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Zexone TZ 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Zexone TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Zexone TZ 250mg/31.25mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zexone TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Zexone TZ (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the dosage of Zexone TZ (250mg/31.25mg) injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Zexone TZ 250mg/31.25mg Injection :
Omit a Zexone TZ 250mg/31.25mg Injection dose? Seek your physician's advice.
Facts to Know About Zexone TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently